LATEST
GTCR agreed to acquire CCC Intelligent SolutionsnewEQT agreed to acquire StockbridgenewProofpoint agreed to acquire VaronisnewMubadala Capital acquired Clear Channel OutdoorIthaca Holdings agreed to acquire BumblePenta Fine Ingredients acquired SynerzineHexagon agreed to acquire RocscienceSRS Acquiom / PantaraiSpaceX agreed to acquire nationwide 800 MHz spectrum portfolioAEA Investors acquired RensaWittington Investments agreed to acquire BootsEurazeo / MIYA Water: majority stake
Open App
ClosedPublished 14 Jul 2026

Ligand Pharmaceuticals Incorporated /
XOMA Royalty

Ligand to acquire XOMA Royalty in cash-and-CVR deal, now closed

Buy side: Ligand Pharmaceuticals Incorporated
Buy sideLigand Pharmaceuticals Incorporated
Target: XOMA Royalty
TargetXOMA Royalty
XOMA Royalty Corp · 14 Jul 2026Source
See the source
Follow Ligand Pharmaceuticals Incorporated Follow XOMA Royalty
Buy side: Ligand Pharmaceuticals Incorporated
Buy sideLigand Pharmaceuticals Incorporated
Target: XOMA Royalty
TargetXOMA Royalty
01 / BuyerLigand Pharmaceuticals Incorporated
02 / TargetXOMA Royalty
Source for the buyer and target: XOMA Royalty Corp

For the buyer and target.

“XOMA Royalty Corporation today announced that Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) has completed its previously announced acquisition of XOMA Royalty.”

Published 14 Jul 2026

Open the source
01

What happened

Ligand Pharmaceuticals completed its merger with XOMA Royalty on July 14, 2026. Under the agreement, XOMA Royalty shareholders receive $39.00 per share in cash plus contingent value rights tied to XOMA Royalty LLC. [01]

XOMA Royalty's common stock and preferred shares are being removed from Nasdaq, and the company plans to deregister with the SEC. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · XOMA Royalty Corp

Ligand to acquire XOMA Royalty in cash-and-CVR deal, now closed

This document is the source for the companies, stage, figure and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Closed

    “Ligand to acquire XOMA Royalty in cash-and-CVR deal, now closed Ligand Pharmaceuticals completed its merger with XOMA Royalty on July 14, 2026”

    Open the source

  2. Published by XOMA Royalty Corp

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.

04

Deal Web

Every firm and person on this deal, and how they connect. Open any name to see their other deals.

Deal Web · 2 firms · 0 peopleHover a name to see how it connects
This dealLigand Pharmaceuticals Incorporated / XOMA RoyaltyClosed · Published 14 Jul 2026
BuyerLigand Pharmaceuticals IncorporatedTargetXOMA Royalty
This dealLigand Pharmaceuticals Incorporated / XOMA Royalty

Closed · Ligand Pharmaceuticals Incorporated / XOMA Royalty deal (Closed, published 14 Jul 2026).

Closed 14 Jul 2026
Timeline
  1. Closed
  2. Published by XOMA Royalty Corp
Hover or tap a name to see how it connects, and when
Deal Web as a list